Clinical Trial Update: Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

View source ↗

Summary

A Phase IV clinical trial is evaluating the efficacy and safety of vunakizumab for adults with moderate-to-severe plaque psoriasis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Vunakizumab (Vunakizumab)

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Moderate to Severe Plaque Psoriasis | Status: RECRUITING